Today’s ASX announcement marks the end of an era, and a new strategy for former market darling 1-Page Ltd (ASX: 1PG). Listed in 2014, 1-Page enjoyed a meteoric rise and CEO Joanna Riley was feted in media publications. At its peak, the company boasted a share price of $4.94 and a market capitalisation of almost $800 million:
This was despite having only $400,000 in revenue and losing $19 million after tax in financial year 2015.
Ultimately the business performance never lived up to the hype, even though 1-Page announced ‘major’ contracts with Sears, Amazon, Red Bull, Starbucks, and more.
Many have commented on the seeming similarities between 1-Page and current market darling Getswift Ltd (ASX: GSW), a company whose share price has also risen well in advance of its revenue growth. Getswift has also announced major, unquantified, deals with big international clients including Amazon.
While Getswift’s future is not yet written – the stock is currently suspended – 1-Page’s future was sealed in September last year when it sold its core 1-Page business for $1. After a suspension lasting many months, 1-Page announced this morning that it was entering the medical marijuana business via an acquisition of HAPA in Germany.
1-Page will issue 90 million shares and pay 1.3 million euros to the founders of HAPA, who expect to open their first medical marijuana clinics, in Berlin and Dortmund, within the next two months.
Following the acquisition there will be around 240 million 1-page shares on issue, so the HAPA founders will own ~37% of the company. 1-Page will have around $23 million in cash and will change its name to European Cannabis Corporation.
There have been a number of stark lessons in there for those who have owned companies like 1-Page or other similar businesses like Reffind Ltd (ASX: RFN) – Reffind was one I owned. Hopefully 1-Page’s future looks brighter for shareholders than its past does.
It just goes to show you can never count a “software company” out…They might transform into a medical marijuana company instead.
5 stocks under $5
We hear it over and over from investors, "I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I'd be sitting on a gold mine!" And it's true.
And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!
*Extreme Opportunities returns as of June 5th 2020
Motley Fool contributor Sean O'Neill has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
- Results: Is G8 Education Ltd a buy for its 4% dividend? – August 27, 2018 12:22pm
- Results: Why the Adacel Technologies Limited (ASX:ADA) share price is down 7% – August 26, 2018 9:54pm
- Results: Why the Nearmap Ltd (ASX:NEA) share price is up 4% today – August 22, 2018 5:15pm